WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff Relief: ... Chinese pharma firms may have escaped the immediate impact of U.S. President Donald Trump's newly announced 100% tariff on patented drugs, but longer-term threats from Wa...
(9/30/2025)

First Drug Patent Term Extension Granted In Ch... (10/13/2025)

U.S. Senate Approves Revised China Biotech Com... (10/13/2025)

China's Innovative Drug Sector Secures Over CN... (10/13/2025)

Challenges and Opportunities in Oncology Drug ... (9/23/2025)

China's Edge over U.S. Biotech Was Never Scien... (9/23/2025)

China's Role in Global Drug Approvals Expands ... (9/22/2025)

PRC Consolidates Pharmaceutical Supply Chain D... (9/19/2025)

China Biopharma at Crossroads: A... (9/19/2025)

Gottlieb Cautions Blanket China Drug Licensing... (9/19/2025)

Obesity in China (The Lancet) (9/19/2025)

China's Biotechs Navigate the Demands of Inter... (9/19/2025)

On the Cusp of a Cure: Is Asia Pacific Ready f... (9/18/2025)

GSK's Shingrix Wins Chinese Approval for... (10/14/2025) Biokin and SystImmune Present Promising ... (10/14/2025) Multitude Reports Updated Safety and Dos... (10/14/2025) AskBio Reports Promising Safety Results ... (10/14/2025) Huadao Secures Over CNY 100M in Series D... (10/13/2025) Lepu Reports Early Clinical Data for ADC... (10/13/2025) Hansoh Pharma Reports Phase II Data for ... (10/13/2025) Lundbeck's Epilepsy Drug Bexicaserin Gra... (10/13/2025) Two Decades of Pediatric Drug Trials in ... (10/13/2025) CDE Seeks Input on Draft Technical Requi... (10/13/2025) CDE Solicits Comments on Draft Guideline... (10/13/2025) CDE Issues Guidance to Address Common Ch... (10/13/2025) China Introduces New Regulations to Gove... (10/13/2025) AviadoBio and UgeneX Enter Exclusive Opt... (10/13/2025) Huadao Bio Secures Over CNY 100M in Seri... (10/13/2025) Kelun-Biotech Presents Promising Phase 1... (10/13/2025) CF PharmaTech Soars 161% on Hong Kong IP... (10/13/2025) Eccogene Files for Hong Kong IPO (10/13/2025)

China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M... China Drives Asia-Pacific Health Care Transformation Am...

PegBio Signs Exclusive Licensing Term Sheet with UAE's ... Micot Pharma Completes Over CNY 200M Series D Financing... Chengdu NRT Raises ~CNY 800M in Series D Financing to A... Expedition Therapeutics Secures USD 165M in Oversubscri... Walgreens Boots Alliance Fully Exits Nanjing Pharma

China Introduces New Regulations to Govern Clinical Res... CDE Issues Guidance to Address Common Challenges in Ped... CDE Solicits Comments on Draft Guidelines for Bioequiva... CDE Seeks Input on Draft Technical Requirements for Sod... China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Over...

China Expands Medical Insurance Coverage for Rare Disea... China Unveils New Rules for 11th Round of National Cent... China Launches Pilot Program for Real-World Comprehensi... China to Incorporate HPV Vaccines into National Immuniz... NHSA Seeks Feedback on Draft Implementation Rules for M...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola... China's Sharp API Price Cuts Jeopardize India's Self-Re... China Produces Dozens of Drugs Below Market Price – U.... India Moves to Set Minimum Import Prices to Protect Pha...

AskBio Reports Promising Safety Results from First Coho... Multitude Reports Updated Safety and Dose Findings for ... Biokin and SystImmune Present Promising Early Data for ... GSK's Shingrix Wins Chinese Approval for Expanded Use CSPC's Novel siRNA Therapy Gains U.S. Green Light for C...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...